7716 Accounts 2009. qxd 16 6 09 16:29 Page 126 126 BTG plc Annual Report 2009 Five-year financial record Five-year financial record For the years ended 31 March Income statement 1 2 2009 2008 2007 2006 2005 m m m m m Revenue 84.8 75.0 45.7 50.2 38.3 Cost of sales 37.1 32.1 18.9 20.7 15.7 Gross profit 47.7 42.9 26.8 29.5 22.6 Operating and administrative expenses 20.6 13.8 18.9 24.3 31.6 Restructuring costs 10.9 8.1 1.0 3.7 11.8 Operating expenses 31.5 21.9 17.9 28.0 43.4 Research and development 21.2 12.2 9.0 8.1 15.8 Share of results of associates 0.4 0.7 0.7 1.0 1.0 Research and development expenses 21.6 12.9 9.7 9.1 16.8 Profit on disposal of assets and investments 2.6 0.4 2.7 11.6 2.2 Amounts written off associates and investments 3.4 1.0 4.2 1.0 Amortisation of business combination intangibles 3.0 Operating loss profit 9.2 8.5 0.9 0.2 36.4 Net financial income 2.1 2.2 1.7 1.7 1.6 Loss profit before tax 11.3 10.7 2.6 1.5 34.8 Tax 1.8 1.9 0.2 0.1 0.2 Loss profit after tax for the year 1 3.
1 8.8 2.4 1.4 35.0 Attributable to: Equity holders of the parent 1 3.
1 8.8 2.4 1.5 34.7 Minority interest 0.1 0.3 Loss profit after tax for the year 1 3.
1 8.8 2.4 1.4 35.0 Basic and diluted loss earnings per share 7.1p 5.9p 1.6p 1.0p 23.8p Gross profit 2009 2008 2007 2006 2005 m m m m m Royalties from launched products 32.1 24.9 24.2 23.0 17.8 Income from new agreements and milestone payments 11.0 18.0 2.6 6.5 4.8 Gross profit from product sales 4.6 Gross profit 47.7 42.9 26.8 29.5 22.6 1 The results for the year ended 31 March 2009 include the results of Protherics from the date of acquisition, being 4 December 2008.
2 The results for the year ended 31 March 2005 have been restated following the change to IFRS.
2 The balance sheet for 31 March 2005 has been restated following the change to IFRSs.
Consolidated cash flow statement 1 2 2009 2008 2007 2006 2005 m m m m m Net cash used in from operating activities 1.8 13.4 3.1 7.0 30.0 Net cash from used in investing activities 21.8 0.8 5.4 19.1 2.0 Net cash from financing activities 0.1 0.8 4.3 Increase decrease in cash and cash equivalents 19.9 14.2 7.7 16.4 32.0 Effect of exchange rate fluctuations on cash held 1.3 0.2 0.3 0.1 Cash and cash equivalents at start of year 57.0 43.0 51.0 34.5 66.5 Cash and cash equivalents at end of year 78.2 57.0 43.0 51.0 34.5 1 The results for the year ended 31 March 2009 include the results of Protherics from the date of acquisition, being 4 December 2008.
